Skip to content

Ocular Therapeutix OCUL Prepaid & Other Current

Prepaid & Other Current at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$620.9M+32.4%
Bausch + Lomb logo
Bausch + LombBLCO
$414M-6.1%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$5.73M+49.4%
PBH
Prestige Consumer HealthcarePBH
$16.56M+96.2%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$31.98M+39.4%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$23.52M+47.0%

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.21B+58.2%
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's prepaid & other current?
Ocular Therapeutix (OCUL) reported prepaid & other current of $11.21M in Q1 2026.
How has Ocular Therapeutix's prepaid & other current changed year-over-year?
Ocular Therapeutix's prepaid & other current increased by 17.7% year-over-year, from $9.52M to $11.21M.
What is the long-term trend for Ocular Therapeutix's prepaid & other current?
Over 5 years (2020 to 2025), Ocular Therapeutix's prepaid & other current has grown at a 18.5% compound annual growth rate (CAGR), from $4.65M to $10.86M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.